FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317781006> ?p ?o ?g. }

• W4317781006 endingPage "1575" @default.
• W4317781006 startingPage "1563" @default.
• W4317781006 abstract "Abstract Background Telomere maintenance mechanisms are required to enable the replicative immortality of malignant cells. While most cancers activate the enzyme telomerase, a subset of cancers uses telomerase-independent mechanisms termed alternative lengthening of telomeres (ALT). ALT occurs via homology-directed-repair mechanisms and is frequently associated with ATRX mutations. We previously showed that a subset of adult glioblastoma (GBM) patients with ATRX-expressing ALT-positive tumors harbored loss-of-function mutations in the SMARCAL1 gene, which encodes an annealing helicase involved in replication fork remodeling and the resolution of replication stress. However, the causative relationship between SMARCAL1 deficiency, tumorigenesis, and de novo telomere synthesis is not understood. Methods We used a patient-derived ALT-positive GBM cell line with native SMARCAL1 deficiency to investigate the role of SMARCAL1 in ALT-mediated de novo telomere synthesis, replication stress, and gliomagenesis in vivo. Results Inducible rescue of SMARCAL1 expression suppresses ALT indicators and inhibits de novo telomere synthesis in GBM and osteosarcoma cells, suggesting that SMARCAL1 deficiency plays a functional role in ALT induction in cancers that natively lack SMARCAL1 function. SMARCAL1-deficient ALT-positive cells can be serially propagated in vivo in the absence of detectable telomerase activity, demonstrating that the SMARCAL1-deficient ALT phenotype maintains telomeres in a manner that promotes tumorigenesis. Conclusions SMARCAL1 deficiency is permissive to ALT and promotes gliomagenesis. Inducible rescue of SMARCAL1 in ALT-positive cell lines permits the dynamic modulation of ALT activity, which will be valuable for future studies aimed at understanding the mechanisms of ALT and identifying novel anticancer therapeutics that target the ALT phenotype." @default.
• W4317781006 created "2023-01-24" @default.
• W4317781006 creator A5003944261 @default.
• W4317781006 creator A5015791191 @default.
• W4317781006 creator A5025528414 @default.
• W4317781006 creator A5028505407 @default.
• W4317781006 creator A5030844192 @default.
• W4317781006 creator A5038097238 @default.
• W4317781006 creator A5038247833 @default.
• W4317781006 creator A5046670716 @default.
• W4317781006 creator A5060696449 @default.
• W4317781006 creator A5073862375 @default.
• W4317781006 creator A5075776410 @default.
• W4317781006 creator A5088890711 @default.
• W4317781006 date "2023-01-23" @default.
• W4317781006 modified "2023-10-17" @default.
• W4317781006 title "Cancer-associated<i>SMARCAL1</i>loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells" @default.
• W4317781006 cites W1562677361 @default.
• W4317781006 cites W1812256879 @default.
• W4317781006 cites W1921809757 @default.
• W4317781006 cites W1939427383 @default.
• W4317781006 cites W1966346464 @default.
• W4317781006 cites W1986009297 @default.
• W4317781006 cites W1987369038 @default.
• W4317781006 cites W2003285865 @default.
• W4317781006 cites W2026851128 @default.
• W4317781006 cites W2028643362 @default.
• W4317781006 cites W2033420162 @default.
• W4317781006 cites W2103453025 @default.
• W4317781006 cites W2106892764 @default.
• W4317781006 cites W2131117209 @default.
• W4317781006 cites W2133940489 @default.
• W4317781006 cites W2137361994 @default.
• W4317781006 cites W2138207763 @default.
• W4317781006 cites W2141288561 @default.
• W4317781006 cites W2141444502 @default.
• W4317781006 cites W2146512944 @default.
• W4317781006 cites W2154870331 @default.
• W4317781006 cites W2159414441 @default.
• W4317781006 cites W2179438025 @default.
• W4317781006 cites W2193590034 @default.
• W4317781006 cites W2214074259 @default.
• W4317781006 cites W2263990041 @default.
• W4317781006 cites W2532728099 @default.
• W4317781006 cites W2532734448 @default.
• W4317781006 cites W2567956911 @default.
• W4317781006 cites W2612326755 @default.
• W4317781006 cites W2759748330 @default.
• W4317781006 cites W2766649068 @default.
• W4317781006 cites W2791150552 @default.
• W4317781006 cites W2803325987 @default.
• W4317781006 cites W2889146908 @default.
• W4317781006 cites W2889619176 @default.
• W4317781006 cites W2913360660 @default.
• W4317781006 cites W2913719958 @default.
• W4317781006 cites W2947145619 @default.
• W4317781006 cites W2949093503 @default.
• W4317781006 cites W2952660586 @default.
• W4317781006 cites W2969924236 @default.
• W4317781006 cites W3011286997 @default.
• W4317781006 cites W3020844323 @default.
• W4317781006 cites W3039743046 @default.
• W4317781006 cites W3168043565 @default.
• W4317781006 cites W4220908212 @default.
• W4317781006 cites W4283807546 @default.
• W4317781006 cites W4289517688 @default.
• W4317781006 doi "https://doi.org/10.1093/neuonc/noad022" @default.
• W4317781006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36689342" @default.
• W4317781006 hasPublicationYear "2023" @default.
• W4317781006 type Work @default.
• W4317781006 citedByCount "2" @default.
• W4317781006 countsByYear W43177810062023 @default.
• W4317781006 crossrefType "journal-article" @default.
• W4317781006 hasAuthorship W4317781006A5003944261 @default.
• W4317781006 hasAuthorship W4317781006A5015791191 @default.
• W4317781006 hasAuthorship W4317781006A5025528414 @default.
• W4317781006 hasAuthorship W4317781006A5028505407 @default.
• W4317781006 hasAuthorship W4317781006A5030844192 @default.
• W4317781006 hasAuthorship W4317781006A5038097238 @default.
• W4317781006 hasAuthorship W4317781006A5038247833 @default.
• W4317781006 hasAuthorship W4317781006A5046670716 @default.
• W4317781006 hasAuthorship W4317781006A5060696449 @default.
• W4317781006 hasAuthorship W4317781006A5073862375 @default.
• W4317781006 hasAuthorship W4317781006A5075776410 @default.
• W4317781006 hasAuthorship W4317781006A5088890711 @default.
• W4317781006 hasBestOaLocation W43177810062 @default.
• W4317781006 hasConcept C104317684 @default.
• W4317781006 hasConcept C121608353 @default.
• W4317781006 hasConcept C127716648 @default.
• W4317781006 hasConcept C177336024 @default.
• W4317781006 hasConcept C502942594 @default.
• W4317781006 hasConcept C54355233 @default.
• W4317781006 hasConcept C555283112 @default.
• W4317781006 hasConcept C68838962 @default.
• W4317781006 hasConcept C86803240 @default.
• W4317781006 hasConcept C94581717 @default.
• W4317781006 hasConceptScore W4317781006C104317684 @default.
• W4317781006 hasConceptScore W4317781006C121608353 @default.

• next